Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
Bjorn Jensen1, Jeffrey Chen, Tim Furnish
1Center for Pain Medicine, University of California San Diego, 9300 Campus Point Drive, Mail Code 7651, La Jolla, CA, 92037, USA, bbjensen@ucsd.edu.
Abstract:
Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems. The route of delivery of cannabis is important as the bioavailability and metabolism are very different for smoking versus oral/sublingual routes. Gold standard clinical trials are limited; however, some studies have thus far shown evidence to support the use of cannabinoids for some cancer, neuropathic, spasticity, acute pain, and chronic pain conditions.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
Nociception
Pain
Chronic Pancreatitis II: Collaborative Care
Assessment:

